Please assess the completion status of the following clinical trial:

Trial Title: A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Urban of Indigenous Ancestry from the Americas (North, Central and South America)~* Men and women~* BMI Between 30-55~* Not diagnosed with Type II Diabetes~* At least one of the following criterion~  1. Triglycerides: 150mg/dL or higher~ 2. Reduced HDL: \<40mg/dL (men); \<50mg/dL (women)~ 3. Blood pressure: \>130/80 or current treatment with antihypertensives~ 4. Fasting glucose: \>100mg/dL~Exclusion Criteria:~* Significant medical comorbidities, including uncontrolled metabolic disorders (e.g., thyroid, diabetes, renal, liver), unstable heart disease, heart failure, and ongoing substance abuse;~* On greater than 10 prescription medications.~* Psychiatric disorders requiring atypical antipsychotics or multiple medications;~* Inappropriate for moderate exercise according to the Revised Physical Activity Readiness Questionnaire;~* Pregnant, planning to become pregnant, or lactating;~* Family household member already enrolled in the study;~* Already enrolled or planning to enroll in a clinical trial that would limit full participation in the study;~* Resident of a long term care facility;~* Lack of spoken English by patient or a household member \> 18 y who can serve as interpreter;~* Plans to move during the study period (9 months post-randomization);~* Investigator discretion for clinical safety or adherence reasons (e.g., unstable housing, chronic pain).

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard Diabetes Prevention Program (DPP) (Type: ACTIVE_COMPARATOR): Participants receive Standard DPP over the course of 20 weeks.
- Enhanced DPP (Type: EXPERIMENTAL): Participants receive Standard DPP plus Enhanced DPP over the course of 20 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).